| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000032564 |
| Receipt No. | R000036943 |
| Scientific Title | A prospective study of the effectiveness of mesenchymal stem cell therapy for lymphedema |
| Date of disclosure of the study information | 2018/05/14 |
| Last modified on | 2020/05/13 (Ver. 3) |
| Basic information | ||
| Public title | A prospective study of the effectiveness of mesenchymal stem cell therapy for lymphedema | |
| Acronym | Study of MSC for lymphedema | |
| Scientific Title | A prospective study of the effectiveness of mesenchymal stem cell therapy for lymphedema | |
| Scientific Title:Acronym | Study of MSC for lymphedema | |
| Region |
|
|
| Condition | ||
| Condition | Lower limb lymphedema | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate safety and efficacy of transplant of autologous culutured adipose derived stem cells on secondary lower limb lymphedema. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Immediate pre-intervantion and 1, 3, 6 months post intervention volume of edema Visual analogue scale (VAS) of pain Skin stiffness Adverse event:Clavien-dindo classification |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Patients of Unilateral lower limb lymphedema with histerectomy and pelvic lymph node dissection due to cervical and/or uterine cancerwithout radiation therapy. |
|||
| Key exclusion criteria | Patients with active cancer, deep vein thronbosis and/or lymphedema morphologically classified into hyperplasia. | |||
| Target sample size | 5 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Avenue Cell Clinic
|
||||||
| Division name | Avenue Cell Clinic | ||||||
| Zip code | 1070062 | ||||||
| Address | Minami Aoyama 3-18-6, Minato-ku, Tokyo Japan | ||||||
| TEL | 0120-382-300 | ||||||
| kinoue-tky@umin.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Avenue Cell Clinic | ||||||
| Division name | Avenue Cell Clinic | ||||||
| Zip code | 1070062 | ||||||
| Address | Minami Aoyama 3-18-6, Minato-ku, Tokyo Japan | ||||||
| TEL | 0120-382-300 | ||||||
| Homepage URL | |||||||
| kinoue-tky@umin.ac.jp | |||||||
| Sponsor | |
| Institute | Avenue Cell Clinic |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Avenue Cell Clinic |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | NPO MINS committee |
| Address | 5-20-9-401 Mita, Minato-Ku, Tokyo, JAPAN |
| Tel | 03-6416-1868 |
| npo-mins@j-irb.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Immediate pre-intervantion and 1, 3, 6 months post intervention
volume of edema Visual analogue scale (VAS) of pain Skin stiffness Adverse event:Clavien-dindo classification |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000036943 |